Calming And Sleeping Products in Brazil

Table of Contents

• OTC HEALTHCARE IN BRAZIL : MARKET INSIGHT
• EXECUTIVE SUMMARY
• Positive economy indicators push sales of OTC healthcare
• New rules for OTC advertising
• Hypermarcas acquires DM Indústria Farmacêutica and Farmasa
• Further consolidation of drugstores
• Slowdown growth in the next two years
• KEY TRENDS AND DEVELOPMENTS
• Further restriction to advertising of OTC products
• Hypermarcas acquires two leading OTC manufacturers
• Specific department for OTC products established within ANVISA
• Financial crisis affects OTC products
• Senior consumers and women over 40 years old attract investment
• MARKET INDICATORS
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
• MARKET DATA
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
• APPENDIX
• OTC Registration and Classification
• De-reimbursement
• Advertising
• Packaging and labelling
• Distribution
• Vitamins and Dietary Supplements Registration and Classification
• Self-medication and Preventative Medicine
• Generics
• Switches
  • Summary 1 OTC Healthcare Switches 2005-2007
• DEFINITIONS
  • Summary 2 Research Sources
• LOCAL COMPANY PROFILES - BRAZIL
• ACHé LABORATóRIOS FARMACêUTICOS SA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 3 Aché Laboratórios Farmacêuticos SA: Key Facts
  • Summary 4 Aché Laboratórios Farmacêuticos SA:
• Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 5 Aché Laboratórios Farmacêuticos SA: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 6 Aché Laboratórios Farmacêuticos SA: Competitive Position 2008
• BAYER SA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 7 Bayer SA: Key Facts
  • Summary 8 Bayer SA: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 9 Bayer SA: Competitive Position 2008
• BOEHRINGER INGELHEIM DO BRASIL QUíMICA E FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 10 Boehringer Ingelheim do BrasilQuímica e Farmacêutica Ltda: Key Facts
  • Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 12 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 13 Boehringer Ingelheim do BrasilQuímica e Farmacêutica Ltda: Competitive Position 2008
• DM INDúSTRIA FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 14 DM Indústria Farmacêutica Ltda: Key Facts
  • Summary 15 DM Indústria Farmacêutica Ltda: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 16 DM Indústria Farmacêutica Ltda: Competitive Position 2008
• EMS SA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 17 EMS SA: Key Facts
  • Summary 18 EMS SA: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 19 EMS SA: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 20 EMS SA: Competitive Position 2008
• EUROFARMA LABORATóRIO LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 21 Eurofarma Laboratório Ltda: Key Facts
  • Summary 22 Eurofarma Laboratório Ltda: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 23 EurofarmaLaboratório Ltda: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 24 Eurofarma Laboratório Ltda: Competitive Position 2008
• JANSSEN-CILAG FARMACEUTICA LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 25 Janssen-Cilag Farmacêutica Ltda: Key Facts
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 26 Janssen-Cilag Farmacêutica Ltda: Competitive Position 2008
• MEDLEY SA INDúSTRIA FARMACêUTICA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 27 Medley SA Indústria Farmacêutica: Key Facts
  • Summary 28 Medley SA Indústria Farmacêutica: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 29 Medley SA Indústria Farmacêutica: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 30 Medley SA Indústria Farmacêutica: Competitive Position 2008
• NYCOMED PHARMA LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 31 Nycomed Pharma Ltda: Key Facts
  • Summary 32 Nycomed Pharma Ltda: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
  • Summary 33 Nycomed Pharma Ltda: Production Statistics 2007
• COMPETITIVE POSITIONING
  • Summary 34 Nycomed Pharma Ltda: Competitive Position 2008
• SANOFI-AVENTIS FARMACêUTICA LTDA - OTC HEALTHCARE - BRAZIL
• STRATEGIC DIRECTION
• KEY FACTS
  • Summary 35 Sanofi-Aventis Farmacêutica Ltda: Key Facts
  • Summary 36 Sanofi-AventisFarmacêutica Ltda: Operational Indicators
• COMPANY BACKGROUND
• PRODUCTION
• COMPETITIVE POSITIONING
  • Summary 37 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2008
• CALMING AND SLEEPING PRODUCTS IN BRAZIL
• HEADLINES
• SECTOR DATA
  • Table 11 Sales of Calming and Sleeping Products: Value 2003-2008
  • Table 12 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
  • Table 13 Calming and Sleeping Products Company Shares by Value 2004-2008
  • Table 14 Calming and Sleeping Products Brand Shares by Value 2005-2008
  • Table 15 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
  • Table 16 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013